echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Domestic ECMO successfully approved for listing! The domestic high-end medical equipment industry is ushering in a new breakthrough

    Domestic ECMO successfully approved for listing! The domestic high-end medical equipment industry is ushering in a new breakthrough

    • Last Update: 2023-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Shortly after the start of the new year, there was good news in the domestic high-end medical equipment industry
    .
    On January 9, the Ministry of Industry and Information Technology issued a new development on "China's first domestic extracorporeal membrane oxygenation machine (ECMO) successfully developed", the announcement shows that on January 6, 2023, China's first domestic extracorporeal membrane oxygenation machine (ECMO) medical device marketing certification ceremony was held in Shenzhen, and the State Food and Drug Administration issued Shenzhen Hannuo ECMO complete machine and supporting consumables medical device registration certificate and production license
    .
    Behind the successful approval of domestic ECMO for listing, it reflects that the domestic high-end medical equipment industry is ushering in a new breakthrough
    .

     
    The first domestic ECMO was successfully developed
     
    Extracorporeal membrane oxygenation system (ECMO) is a key medical equipment for the treatment of acute respiratory failure, cardiopulmonary failure and other patients, mainly used to provide long-term extracorporeal cardiopulmonary support for patients with cardiopulmonary failure, assist breathing and blood circulation, and maintain the life
    of patients.

     
    In the past, China lacked the key technologies and processes of many core components of ECMO, and was mainly "stuck in the neck"
    by countries such as Europe and the United States.
    It is reported that Shenzhen Hannuo has gradually overcome the problems with the support of the National High-performance Medical Device Innovation Center and achieved major breakthroughs
    in the design, research and development, manufacturing and core components of ECMO.

     
    With the listing of China's ECMO, it means that a major shortcoming in the field of high-end medical equipment for critical care in China will be filled
    .
    It is reported that the ECMO produced in China will be applied to the clinical line as soon as possible and play a role
    in the treatment of critically ill patients as soon as possible.

     
    The domestic high-end medical equipment industry is ushering in a new breakthrough
     
    High-end medical equipment is a powerful guarantee
    for people's health and life safety.
    At present, the overall domestic medical equipment is still in the low-end market, while high-end medical equipment has a low
    degree of localization due to high technical barriers.

     
    In order to implement the strategy of manufacturing a strong country and make up for the shortcomings of China's high-end medical equipment, relevant departments have made concerted efforts in recent years, and favorable policies and measures have been continuously released, such as the "14th Five-Year Plan" National Health Plan, the "14th Five-Year Plan" Medical Equipment Industry Development Plan, etc.
    , of which the "14th Five-Year Plan" medical equipment industry development plan will "improve the modernization level of the industrial chain and supply chain" as one of
    the five key tasks.
    This means that China's medical equipment industry has entered a period of high-quality development, and it is very important to
    ensure the independent and controllable industrial chain and supply chain.

     
    With the release of a series of favorable policies, enterprises in the industrial field have accelerated their progress towards high-quality development by increasing investment in research and development, strengthening technical research, and accelerating the process of domestic substitution of high-end medical devices, and news of product breakthroughs continues
    。 In addition to the first domestic ECMO listed, for example, Neusoft Medical released the first domestic high-end optical fiber distributed spectrometer NeuMR Rena famous magnetic resonance on June 15, 2022, which is a large-scale medical device independently developed by the company, which has long been monopolized by foreign companies; On December 30, United Imaging Medical released the industry's first intelligent bionic minimally invasive interventional surgery system, uAngio 960, which integrates innovative technologies such as artificial intelligence, digital twin, and multimodal fusion, which will promote interventional surgery into the era of intelligent precision diagnosis and treatment, and make up for China's shortcomings in the field of high-end intelligent minimally invasive interventional surgery systems
    .

     
    Looking at the current domestic medical equipment industry, including high-end medical equipment for critical treatment, medical imaging, intelligent minimally invasive interventional surgery systems and other fields, there have been beautiful landscapes created by domestic enterprises
    .
    Among them, in the field of medical imaging, which has attracted much attention, the current local terminal equipment manufacturers include traditional head enterprises such as Neusoft Medical, Mindray Medical, and Wandong Medical, as well as cutting-edge forces such as United Imaging Medical, Mingfeng Medical, and Sinovison, and domestic brands are constantly encroaching on multinational enterprises
    in the field of domestic high-end medical equipment.
    According to data, in the first half of 2022, Neusoft Medical and United Imaging Medical, two leading companies in the field of local medical imaging, have refreshed domestic alternative data on domestic CT sales that have exceeded those of Siemens
    , which has occupied the market for many years.

     
    Looking forward to the future, with the continuous improvement of domestic enterprises' self-research and self-control capabilities, the industry expects that the rise of domestic brands will accelerate in the future, and more local enterprises will emerge in the high-end medical equipment market
    .

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.